Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir (Q40701431)

22 September 2017

title

Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir (English)

1 reference

22 September 2017

1 reference

Paul R Kinchington

1

1 reference

22 September 2017

Trinita Araullo-Cruz

2

1 reference

22 September 2017

Jean-Paul Vergnes

3

1 reference

22 September 2017

Kathleen Yates

4

1 reference

22 September 2017

Y Jerold Gordon

5

1 reference

22 September 2017

publication date

1 October 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

56

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

73-84

1 reference

Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Antitumor Potential of Acyclic Nucleoside Phosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Progress in understanding cytomegalovirus drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

1 reference

7 January 2021

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Cidofovir in the treatment of cytomegaloviral disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

1 reference

7 January 2021

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Physical mapping of two temperature-sensitive adenovirus mutants affected in the DNA polymerase and DNA binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900098-0

7 January 2021

10.1016/S0166-3542(02)00098-0

Identifiers

DOI

1 reference

release_zc353vjtajentmt46fqbkoomr4

22 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zc353vjtajentmt46fqbkoomr4

24 November 2022

mapped directly with Wikidata item

1 reference